Radiopharmaceutical company Telix aims for $202M IPO
Amid booming interest in radiopharmaceuticals, Telix Pharmaceuticals is planning to become a publicly traded company in the US.
The biotech, based in North Melbourne, Australia …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
